328 related articles for article (PubMed ID: 18771929)
1. Specific binding capacity of beta-cyclodextrin with cis and trans enalapril: physicochemical characterization and structural studies by molecular modeling.
Zoppi A; Quevedo MA; Longhi MR
Bioorg Med Chem; 2008 Sep; 16(18):8403-12. PubMed ID: 18771929
[TBL] [Abstract][Full Text] [Related]
2. Physicochemical, in silico and in vivo evaluation of a danazol-beta-cyclodextrin complex.
Jadhav GS; Vavia PR
Int J Pharm; 2008 Mar; 352(1-2):5-16. PubMed ID: 18023545
[TBL] [Abstract][Full Text] [Related]
3. Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin.
Figueiras A; Carvalho RA; Ribeiro L; Torres-Labandeira JJ; Veiga FJ
Eur J Pharm Biopharm; 2007 Sep; 67(2):531-9. PubMed ID: 17451924
[TBL] [Abstract][Full Text] [Related]
4. Study of ascorbic acid interaction with hydroxypropyl-beta-cyclodextrin and triethanolamine, separately and in combination.
Garnero C; Longhi M
J Pharm Biomed Anal; 2007 Nov; 45(4):536-45. PubMed ID: 17851014
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the 13-cis-retinoic acid/cyclodextrin inclusion complexes by phase solubility, photostability, physicochemical and computational analysis.
Yap KL; Liu X; Thenmozhiyal JC; Ho PC
Eur J Pharm Sci; 2005 May; 25(1):49-56. PubMed ID: 15854800
[TBL] [Abstract][Full Text] [Related]
6. Inclusion complexation of chloropropham with β-cyclodextrin: preparation, characterization and molecular modeling.
Ge X; He J; Qi F; Yang Y; Huang Z; Lu R; Huang L
Spectrochim Acta A Mol Biomol Spectrosc; 2011 Oct; 81(1):397-403. PubMed ID: 21757399
[TBL] [Abstract][Full Text] [Related]
7. Novel pharmaceutical composition of bradykinin potentiating penta peptide with beta-cyclodextrin: physical-chemical characterization and anti-hypertensive evaluation.
Denadai AM; Ianzer D; Alcântara AF; Santoro MM; Santos CF; Lula IS; de Camargo AC; Faljoni-Alario A; dos Santos RA; Sinisterra RD
Int J Pharm; 2007 May; 336(1):90-8. PubMed ID: 17196774
[TBL] [Abstract][Full Text] [Related]
8. Isothermal titration calorimetry and 1H NMR studies on host-guest interaction of paeonol and two of its isomers with beta-cyclodextrin.
Sun DZ; Li L; Qiu XM; Liu F; Yin BL
Int J Pharm; 2006 Jun; 316(1-2):7-13. PubMed ID: 16554127
[TBL] [Abstract][Full Text] [Related]
9. Spectral characteristics of tramadol in different solvents and beta-cyclodextrin.
Anton Smith A; Manavalan R; Kannan K; Rajendiran N
Spectrochim Acta A Mol Biomol Spectrosc; 2009 Oct; 74(2):469-77. PubMed ID: 19665424
[TBL] [Abstract][Full Text] [Related]
10. Preparation and study on the inclusion complexes of two tanshinone compounds with beta-cyclodextrin.
Yuexian F; Junfen L; Chuan D
Spectrochim Acta A Mol Biomol Spectrosc; 2005 Jan; 61(1-2):135-40. PubMed ID: 15556431
[TBL] [Abstract][Full Text] [Related]
11. Nuclear magnetic resonance investigations of the inclusion complexation of gliclazide with beta-cyclodextrin.
Moyano JR; Arias-Blanco MJ; Gines JM; Rabasco AM; Pérez-Martínez JI; Mor M; Giordano F
J Pharm Sci; 1997 Jan; 86(1):72-5. PubMed ID: 9002462
[TBL] [Abstract][Full Text] [Related]
12. Effect of the acyl group and the dodecylsulfonate chain on the inclusion of pyrene inside the cavity of beta-cyclodextrin.
Rima J; Kyriacos S; Rida MA
Spectrochim Acta A Mol Biomol Spectrosc; 2009 Sep; 74(1):10-5. PubMed ID: 19592293
[TBL] [Abstract][Full Text] [Related]
13. Inclusion complex of fenbufen with beta-cyclodextrin.
Bratu I; Gavira-Vallejo JM; Hernanz A; Bogdan M; Bora G
Biopolymers; 2004 Mar; 73(4):451-6. PubMed ID: 14991662
[TBL] [Abstract][Full Text] [Related]
14. Study of the physicochemical properties of trimethoprim with beta-cyclodextrin in solution.
Li N; Zhang YH; Xiong XL; Li ZG; Jin XH; Wu YN
J Pharm Biomed Anal; 2005 Jun; 38(2):370-4. PubMed ID: 15925234
[TBL] [Abstract][Full Text] [Related]
15. Studies of inclusion complexes of natural and modified cyclodextrin with (+)catechin by NMR and molecular modeling.
Jullian C; Miranda S; Zapata-Torres G; Mendizábal F; Olea-Azar C
Bioorg Med Chem; 2007 May; 15(9):3217-24. PubMed ID: 17350847
[TBL] [Abstract][Full Text] [Related]
16. Inclusion of Paracetamol into β-cyclodextrin nanocavities in solution and in the solid state.
El-Kemary M; Sobhy S; El-Daly S; Abdel-Shafi A
Spectrochim Acta A Mol Biomol Spectrosc; 2011 Sep; 79(5):1904-8. PubMed ID: 21703916
[TBL] [Abstract][Full Text] [Related]
17. 1H NMR spectroscopic study of complexation of citalopram with beta-cyclodextrin in aqueous solution.
Mashhood Ali S; Maheshwari A; Inder Fozdar B
Magn Reson Chem; 2007 Mar; 45(3):253-6. PubMed ID: 17290386
[TBL] [Abstract][Full Text] [Related]
18. Optimal configurations of "capped" beta-cyclodextrin dimers in water maximise hydrophobic association.
Gamieldien MR; Maestre I; Jaime C; Naidoo KJ
Chemphyschem; 2010 Feb; 11(2):452-9. PubMed ID: 20014087
[TBL] [Abstract][Full Text] [Related]
19. Investigation of the binding of roxatidine acetate hydrochloride with cyclomaltoheptaose (β-cyclodextrin) using IR and NMR spectroscopy.
Maheshwari A; Sharma M; Sharma D
Carbohydr Res; 2011 Sep; 346(13):1809-13. PubMed ID: 21816394
[TBL] [Abstract][Full Text] [Related]
20. Complexation study of midazolam hydrochloride with beta-cyclodextrin: NMR spectroscopic study in solution.
Ali SM; Upadhyay SK
Magn Reson Chem; 2008 Jul; 46(7):676-9. PubMed ID: 18381674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
